Ⅱ型神经纤维瘤病治疗策略

doi:10.3877/cma.j.issn.2095-9141.2017.02.013

神经纤维瘤病是源于神经嵴细胞分化异常而导致的多系统损害的常染色体显性遗传性疾病，常累及神经、肌肉、骨骼、内脏及皮肤。神经纤维瘤病是一种先天性发育不良性疾病，根据其临床特点和责任基因的不同可分为I型（NF1）和Ⅱ型（NF2）两种类型。与Ⅰ型神经纤维瘤病相比，Ⅱ型神经纤维瘤病的发病率更低。约为3/10万患者发生前庭神经许旺细胞瘤和其他肿瘤，包括脑膜瘤、室管膜瘤和星形细胞瘤等以及外周神经许旺细胞瘤。许多患者还可出现晶状体囊混浊。

关键词: 神经纤维瘤, 遗传, 肿瘤

Neurofibromatosis is an autosomal dominant disorder caused by abnormal differentiation of neural crest cells, which often involves the nerve, muscle, bone, internal organs and skin. Neurofibromatosis is a congenital development benign disease, according to its clinical characteristics and responsibilities gene of different type can be divided into type I (NF1) and Ⅱ (NF2) two types. Compared with type I, neurofibromatosis type Ⅱ has a lower incidence of neurofibromatosis. About 3/10 of all patients with vestibular nerve schwann cell tumor and other tumours, including meningiomas, ependymoma and astrocytoma and peripheral nerve schwann cell tumor. Many patients also can appear capsule opacity.

Key words: Pathogenesis, Heredity, Tumour

[1]	Szudek J, Briggs R, Leung R. Surgery for neurofibromatosis 2[J]. Curr Opin Otolaryngol Head Neck Surg, 2012, 20(5): 347-352.
[2]	赵赋，王博，杨智君,等. 2型神经纤维瘤病前庭神经鞘瘤的显微外科治疗[J].中华神经外科杂志, 2014, 30(11): 1153-1156.
[3]	Plotkin SR, Merker VL, Muzikansky A, et al. Natural history of vestibular schwannoma growth and hearing decline in newly diagnosed neurofibromatosis type 2 patients[J]. Otol Neurotol, 2014, 35(1): e50-56.
[4]	Shepard TH, Tucci DL, Grant GA, et al. Management of hearing in pediatric NF2[J]. Otol Neurotol, 2012, 33(6): 1066-1070.
[5]	Stachowicz-Stencel T, Synakiewicz A, Bien E, et al. Multiple primary cranio-spinal tumours in a 13-year-old female with neurofibromatosis type 2 managementstrategy[J]. Childs Nerv Syst, 2011, 27(1): 175-178
[6]	Kontorinis G, Nichani J, Freeman SR, et al. Progress of hearing loss in neurofibromatosis type 2: implications for future management[J]. Eur Arch Otorhinolaryngol, 2015, 272(11): 3143-3150.
[7]	Nowak A, Dziedzic T, Czernicki T, et al. Clinical course and management of intracranial meningiomas in neurofibromatosis type 2 patients[J]. Neurol Neurochir Pol, 2015, 49(6): 367-372.
[8]	Samii M, Matthies C, Tatagiba M. Management of vestibular schwannomas (acoustic neuromas): auditory and facial nerve function after resection of 120 vestibular schwannomas in patients with neurofibromatosis 2[J]. Neurosurgery, 1997, 40(4):696-705.
[9]	van de Langenberg R, Hanssens PE, van Overbeeke JJ, et al. Management of large vestibular schwannoma. Part I. Planned subtotal resection followed by Gamma Knife surgery: radiological and clinical aspects[J]. J Neurosurg, 2011, 115(5): 875-884.
[10]	Rowe J, Radatz M, Kemeny A. Radiosurgery for type II neurofibromatosis[J]. Prog Neurol Surg, 2008, 21: 176-182.
[11]	Rowe JG, Radatz MW, Walton L, et al. Clinical experience with gamma knife stereotactic radiosurgery in the management of vestibular schwannomas secondary to type 2 neurofibromatosis[J]. J Neurol Neurosurg Psychiatry, 2003, 74(9): 1288-1293.
[12]	Sharma MS, Singh R, Kale SS, et al. Tumor control and hearing preservation after Gamma Knife radiosurgery for vestibular schwannomas inneurofibromatosis type 2[J]. J Neurooncol, 2010, 98(2): 265-270.
[13]	Subach BR, Kondziolka D, Lunsford LD, et al. Stereotactic radiosurgery in the management of acoustic neuromas associated with neurofibromatosis Type 2[J]. J Neurosurg, 2013, 119 Suppl: 815-822.
[14]	Mathieu D, Kondziolka D, Flickinger JC, et al. Stereotactic radiosurgery for vestibular schwannomas in patients with neurofibromatosis type 2: an analysis of tumor control, complications, and hearing preservation rates[J]. Neurosurgery, 2007, 60(3): 460-468.
[15]	Kondziolka D, Subach BR, Lunsford LD, et al. Outcomes after gamma knife radiosurgery in solitary acoustic tumors and neurofibromatosis type 2[J]. Neurosurg Focus, 1998, 5(3): E4.
[16]	Wowra B, Muacevic A, Jess-Hempen A, et al. Outpatient gamma knife surgery for vestibular schwannoma: definition of the therapeutic profile based on a 10-year experience[J]. J Neurosurg, 2013, 119 Suppl: 114-118.
[17]	Maniakas A, Saliba I. Microsurgery versus stereotactic radiation for small vestibular schwannomas: a meta-analysis of patients with more than 5 years′ follow-up[J]. Otol Neurotol, 2012, 33(9): 1611-1620.
[18]	孙健，杨学军，李罡,等. Ⅱ型神经纤维瘤病随访50年一例报告[J].中国现代神经疾病杂志, 2007, 7(4): 327-331.
[19]	Jacob A, Robinson LL Jr, Bortman JS, et a1. Nerve of origin, tumor size, hearing preservation, and facial nerve outcomes in 359 vestibular schwannoma resections at a tertiary care academic center[J]. Laryngoscope, 2007, 117(12): 2087-2092.
[20]	Samii M, Gerganov V, Samii A. Microsurgery management of vestibular schwannomas in neurofibromatosis type 2: indications and results[J]. Prog Neurol Surg, 2008, 21: 169-175.
[21]	Moffat DA, Lloyd SK, Macfarlane R, et al. Outcome of translabyrinthine surgery for vestibular schwannoma in neurofibromatosis type 2[J]. Br J Neurosurg, 2013, 27(4): 446-453.
[22]	Odat HA, Piccirillo E, Sequino G, et al. Management strategy of vestibular schwannoma in neurofibromatosis type 2[J]. Otol Neurotol, 2011, 32(7): 1163-1170.
[23]	Tysome JR, Macfarlane R, Durie-Gair J, et al. Surgical management of vestibular schwannomas and hearing rehabilitation in neurofibromatosis type 2[J]. Otol Neurotol, 2012, 33(3): 466-472.
[24]	Martuza RL, E1dridge R. Neufofibromatosis 2(bilateral acoutic neurofibromatosis)[J]. N Engl J Med, 1988, 318(11): 684-688.
[25]	陈炳恒，王象昌，王宜崇.一次性切除两侧听神经瘤并保留面神经的成功经验[J].中华神经外科杂志, 1985, 1(4): 209.
[26]	Slattery WH, Hoa M, Bonne N, et a1. Middle fossa decompression for hearing preservation：a review of institutional results and indications[J]. Otol Neurotol, 2011, 32(6): 1017-1024.
[27]	Montgomery BK, Alimchandani M, Mehta GU, et al. Tumors displaying hybrid schwannoma and neurofibroma features in patients with neurofibromatosis type 2[J]. Clin Neuropathol, 2016, 35(2): 78-83.
[28]	Di Maio S, Malebranche AD, Westerberg B, et al. Hearing preservation after microsurgical resection of large vestibular schwannomas[J]. Neurosurgery, 2011, 68(3): 632-640.
[29]	Strauss C, Bischoff B, Romstöck J, et al. Hearing preservation in medial vestibular schwannomas[J]. J Neurosurg, 2008, 109(1): 70-76.
[30]	Chen LH, Chen L, Liu L, et al. Vestibular schwannoma microsurgery with special reference to facial nerve preservation[J]. Clin Neurol Neurosurg, 2009, 111(1): 47-53.
[31]	Brackmann DE, Fayad JN, Slattery WH 3rd, et al. Early proactive management of vestibular schwannomas in neurofibromatosis type 2[J]. Neurosurgery, 2001, 49(2): 274-280.
[32]	Nowak A, Dziedzic T, Czernicki T, et al. Strategy for the surgical treatment of vestibular schwannomas in patients with neurofibromatosis type 2[J]. Neurol Neurochir Pol, 2015, 49(5): 295-301.
[33]	Slattery WH 3 rd, Fisher LM, Hitselberger W, et a1. Hearing preservation surgery-for neurofibromatosis Type 2-related vestibular schwannoma in pediatric patients[J]. J Neurosurg, 2007, 106 (4 Suppl): 255-260.

[1]	韩丹, 王婷, 肖欢, 朱丽容, 陈镜宇, 唐毅. 超声造影与增强CT对儿童肝脏良恶性病变诊断价值的对比分析[J]. 中华医学超声杂志（电子版）, 2023, 20(09): 939-944.
[2]	郏亚平, 曾书娥. 含鳞状细胞癌成分的乳腺化生性癌的超声与病理特征分析[J]. 中华医学超声杂志（电子版）, 2023, 20(08): 844-848.
[3]	燕速, 霍博文, 徐惠宁. 4K荧光腹腔镜扩大右半结肠CME+D3根治术及No.206、No.204组淋巴结清扫术[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 14-14.
[4]	钱龙, 陆晓峰, 王行舟, 杜峻峰, 沈晓菲, 管文贤. 神经系统调控胃肠道肿瘤免疫应答研究进展[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 86-89.
[5]	曹长青, 郭新艳, 高源, 张存, 唐海利, 樊东, 杨小军, 张松, 赵华栋. 肿瘤微环境参与介导HER2阳性乳腺癌曲妥珠单抗耐药的研究进展[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 90-95.
[6]	姚宏伟, 魏鹏宇, 高加勒, 张忠涛. 不断提高腹腔镜右半结肠癌D3根治术的规范化[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 1-4.
[7]	杜晓辉, 崔建新. 腹腔镜右半结肠癌D3根治术淋巴结清扫范围与策略[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 5-8.
[8]	周岩冰, 刘晓东. 腹腔镜右半结肠癌D3根治术消化道吻合重建方式的选择[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 9-13.
[9]	唐旭, 韩冰, 刘威, 陈茹星. 结直肠癌根治术后隐匿性肝转移危险因素分析及预测模型构建[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 16-20.
[10]	张生军, 赵阿静, 李守博, 郝祥宏, 刘敏丽. 高糖通过HGF/c-met通路促进结直肠癌侵袭和迁移的实验研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 21-24.
[11]	张焱辉, 张蛟, 朱志贤. 留置肛管在中低位直肠癌新辅助放化疗后腹腔镜TME术中的临床研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 25-28.
[12]	李凤仪, 李若凡, 高旭, 张超凡. 目标导向液体干预对老年胃肠道肿瘤患者术后血流动力学、胃肠功能恢复的影响[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 29-32.
[13]	李建美, 邓静娟, 杨倩. 两种术式联合治疗肝癌合并肝硬化门静脉高压的安全性及随访评价[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 41-44.
[14]	王军, 刘鲲鹏, 姚兰, 张华, 魏越, 索利斌, 陈骏, 苗成利, 罗成华. 腹膜后肿瘤切除术中大量输血患者的麻醉管理特点与分析[J]. 中华临床医师杂志(电子版), 2023, 17(08): 844-849.
[15]	徐军, 姬园园, 陈君平, 王健. 伴菊形团结构的脑膜瘤合并颅骨侵犯一例并文献复习[J]. 中华临床医师杂志(电子版), 2023, 17(08): 916-919.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Treatment strategies of neurofibromatosis type Ⅱ

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Treatment strategies of neurofibromatosis type Ⅱ